Sally Barbour is the Director of Oncology Pharmacy Programs, PGY2 Oncology Pharmacy Residency Program Director and a Clinical Pharmacist Practitioner at Duke University Medical Center. She maintains a clinical practice in the adult outpatient oncology clinics. She earned her BA from Duke University and her PharmD degree from the University of Texas at Austin. She completed a residency in Pharmacy Practice at the University of Illinois at Chicago and in Oncology Pharmacy Practice at the Audie L. Murphy VA and University of Texas Health Science Center in San Antonio. She has been a Board Certified Oncology Pharmacist since 2001 and obtained her Clinical Pharmacist Practitioner certification in 2005. Dr. Barbour serves as a member of the NCCN Antiemesis Panel, NCCN Educational Programs Advisory Committee, ASCO Antiemetic Guideline Panel and the Pharmacy Committee for the Alliance for Clinical Trials in Oncology. She has served on various HOPA committees as both a member and committee leader and has given numerous international, national, and local professional presentations. In 2001, she co-founded the North Carolina Oncology Pharmacists Association.